Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check5 days agoChange DetectedIgA glomerulonephritis was added as a listed condition, aligning with IgA nephropathy. This text update does not modify study design, eligibility criteria, or measured outcomes.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check26 days agoChange DetectedPage revision history updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive study details appear to have changed, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a 'Show glossary' option and updated the revision stamp to v3.4.0. Capitalization changes were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', replacing the prior lowercase labels.SummaryDifference0.2%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.